Literature DB >> 11739244

Effect of ABT-627 (A-147627), a potent selective ET(A) receptor antagonist, on the cardiopulmonary profile of newborn lambs with surgically-induced diaphragmatic hernia.

M Kavanagh1, B Battistini, S Jean, J Crochetière, L Fournier, J Wessale, T J Opgenorth, R Cloutier, D Major.   

Abstract

1. Postnatal mortality in isolated congenital diaphragmatic hernia (CDH) is mainly related to the associated pulmonary hypertension (PH) and to right-to-left shunting. 2. Endothelins (ETs) are potent vasoconstrictors and pro-mitogenic peptides. Strong evidences support their participation in CDH and in the etiology of PH via the activation of ET(A) receptors (ET(A)-Rs). 3. Evaluation of the effect of ABT-627, a selective non-peptidic ET(A)-R antagonist, given from -15 to 210 min post-delivery (1 mg kg(-1) bolus +0.01 mg kg(-1) h(-1) infusion, i.v.), was conducted in the lamb model of CDH. 4. Severity of CDH was assessed in comparison to untreated controls (n=5). Untreated CDH lambs (n=7) had a higher mean pulmonary arterial pressure (MPAP; P<0.0001), lower mean blood pressure (MBP; P=0.0004), higher MPAP / MBP ratio (P<0.0001), lower arterial pH (P<0.0001), higher paCO(2) (P<0.0001), lower paO(2) (P<0.0001) and lower post-ductal pulsatile SaO(2) (P<0.0001) than untreated controls. 5. Treated controls (n=7) showed a higher MPAP, lower MBP, higher MPAP/MBP ratio, lower arterial pH, higher paCO(2), lower paO(2), lower post-ductal pulsatile SaO(2) and lower plasmatic ir-ET ratios compared to untreated controls (P<0.0001). 6. Treated CDH lambs (n=8) showed a higher MBP (P<0.0001), lower MPAP / MBP ratio (P<0.0001), higher arterial pH (P<0.0001), lower paCO(2) (P<0.0001), higher paO(2) (P=0.0228), higher post-ductal pulsatile SaO(2) (P=0.0016) and lower plasmatic ir-ET ratios (P=0.0247) when compared to untreated CDH lambs. 7. These observations revealed that, although acute perinatal treatment with a selective non-peptidic ET(A)-R antagonist had some adverse effects in controls, it attenuated the progressive cardiopulmonary deterioration that occurred after birth in CDH lambs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739244      PMCID: PMC1572904          DOI: 10.1038/sj.bjp.0704424

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  54 in total

1.  Endothelin ETA and ETB receptors mediate vascular smooth-muscle contraction.

Authors:  D G White; T R Cannon; H Garratt; J W Mundin; M J Sumner; I S Watts
Journal:  J Cardiovasc Pharmacol       Date:  1993       Impact factor: 3.105

2.  The ET(A)-Receptor Antagonist LU 135252 Prevents the Progression of Established Pulmonary Hypertension Induced by Monocrotaline in Rats.

Authors: 
Journal:  J Cardiovasc Pharmacol Ther       Date:  1999-01       Impact factor: 2.457

3.  Pulmonary barotrauma in congenital diaphragmatic hernia: experimental study in lambs.

Authors:  U de Luca; R Cloutier; J M Laberge; L Fournier; H Prendt; D Major; D Edgell; P E Roy; S Roberge; F M Guttman
Journal:  J Pediatr Surg       Date:  1987-04       Impact factor: 2.545

4.  Comparison between a clinical short-cut method and a precise laboratory estimation of intrapulmonary shunt and A-aDO2.

Authors:  L Fournier; D Major
Journal:  Can Anaesth Soc J       Date:  1981-05

5.  Pulmonary vascular balance in congenital diaphragmatic hernia: enhanced endothelin-1 gene expression as a possible cause of pulmonary vasoconstriction.

Authors:  T Okazaki; H S Sharma; S K McCune; D Tibboel
Journal:  J Pediatr Surg       Date:  1998-01       Impact factor: 2.545

6.  Effect of CGS 26303, an endothelin-converting enzyme-neutral endopeptidase inhibitor, on nitrofen-induced congenital diaphragmatic hernia in the rat.

Authors:  M Kavanagh; B Battistini; D Kluth; S Jean; L Fournier; A Y Jeng; D Major; R Cloutier
Journal:  J Pediatr Surg       Date:  2000-05       Impact factor: 2.545

7.  Combined gas ventilation and perfluorochemical tracheal instillation as an alternative treatment for lethal congenital diaphragmatic hernia in lambs.

Authors:  D Major; M Cadenas; R Cloutier; L Fournier; M R Wolfson; T H Shaffer
Journal:  J Pediatr Surg       Date:  1995-08       Impact factor: 2.545

8.  The effect of endothelins on nitric oxide and prostacyclin production from human umbilical vein, porcine aorta and bovine carotid artery endothelial cells in culture.

Authors:  D G White; J W Mundin; M J Sumner; I S Watts
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

9.  Hemodynamics of congenital diaphragmatic hernia in lambs.

Authors:  R T Olivet; W M Rupp; R L Telander; M P Kaye
Journal:  J Pediatr Surg       Date:  1978-06       Impact factor: 2.545

10.  BQ123, an ETA receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells.

Authors:  M A Zamora; E C Dempsey; S J Walchak; T J Stelzner
Journal:  Am J Respir Cell Mol Biol       Date:  1993-10       Impact factor: 6.914

View more
  5 in total

1.  Acute effect of a dual ETA-ETB receptor antagonist on pulmonary arterial vasculature in preterm lamb fetuses with surgically induced diaphragmatic hernia.

Authors:  Eleuthère Stathopoulos; Pierre-Henri Rolland; Géraldine Héry; Catherine de Magnée; Olivier Paut; Emmanuelle Couchot; Olivier Leprêtre; Jean-Michel Guys; Pascal de Lagausie
Journal:  Pediatr Surg Int       Date:  2010-08-10       Impact factor: 1.827

2.  Pulmonary artery endothelial cell dysfunction and decreased populations of highly proliferative endothelial cells in experimental congenital diaphragmatic hernia.

Authors:  Shannon N Acker; Gregory J Seedorf; Steven H Abman; Eva Nozik-Grayck; David A Partrick; Jason Gien
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-11       Impact factor: 5.464

3.  Looking beyond PPHN: the unmet challenge of chronic progressive pulmonary hypertension in the newborn.

Authors:  Candice D Fike; Judy L Aschner
Journal:  Pulm Circ       Date:  2013-11-19       Impact factor: 3.017

4.  Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity.

Authors:  Roberta L Keller; Theresa A Tacy; Karen Hendricks-Munoz; Jie Xu; Anita J Moon-Grady; John Neuhaus; Phillip Moore; Kerilyn K Nobuhara; Sam Hawgood; Jeffrey R Fineman
Journal:  Am J Respir Crit Care Med       Date:  2010-04-22       Impact factor: 21.405

5.  Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease.

Authors:  Hong-Qiang Feng; Nate D Weymouth; Don C Rockey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-19       Impact factor: 4.052

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.